Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Rhea-AI Summary
Mesa Labs (NASDAQ:MLAB) announced that Gary Owens, President and CEO, and John Sakys, CFO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026.
The company will deliver a Formal Presentation at 4:30 p.m. Pacific Time. A live webcast will be accessible via the Events & Presentations section of Mesa Labs' Investor Relations website at https://investors.mesalabs.com/, and an archived replay will be available at the same link after the presentation.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
No peers from the same sector appeared in the momentum scanner and no same‑day peer headlines were recorded, suggesting this update is stock‑specific rather than part of a sector‑wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Earnings date notice | Neutral | +0.4% | Announcement of timing for third quarter fiscal 2026 results release. |
| Nov 12 | Investor conferences | Neutral | -0.2% | Management participation in several investor conferences and related webcasts. |
| Nov 06 | Earnings results | Positive | +0.9% | Q2 FY2026 results with revenue and operating income growth and cost actions. |
| Oct 03 | Earnings date notice | Neutral | +2.9% | Announcement of second quarter FY2026 results release date after market close. |
| Oct 03 | Dividend declaration | Positive | +2.9% | Board declaration of a regular quarterly dividend of $0.16 per share. |
Recent company news has mostly drawn mild positive price reactions, including earnings results and dividend declarations, with one small divergence on a conferences update.
Over the last few months, Mesa Laboratories reported stronger Q2 FY2026 operating results on Nov 6, 2025, with revenue and operating income growth that were followed by a modestly positive price reaction. The company also maintained shareholder returns via a $0.16 quarterly dividend announced on Oct 3, 2025. Multiple earnings‑date and conference participation notices (including in November–December 2025) saw generally small price changes. Today’s J.P. Morgan Healthcare Conference presentation fits this pattern of ongoing investor‑relations outreach rather than a new financial or clinical catalyst.
Market Pulse Summary
This announcement details Mesa Laboratories’ planned presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 4:30 p.m. Pacific Time, with a live and archived webcast available via the investor relations site. It follows a series of prior conference and earnings‑date notices that produced generally modest price moves. Investors may focus on any new financial or strategic commentary delivered at the conference, as this release itself contains no new operating or balance‑sheet data.
AI-generated analysis. Not financial advice.
LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate in a Formal Presentation at 4:30 p.m. Pacific Time.
A live webcast of the presentation will be accessible here and on the Events & Presentations section of Mesa Lab’s Investor Relations website at https://investors.mesalabs.com/. An archived replay of the webcast will be available through the same link following the presentation.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
For more information about Mesa, please visit its website at www.mesalabs.com.
Mesa Laboratories Contacts:
Gary Owens; President and CEO,
John Sakys; CFO
1-303-987-8000
investors@mesalabs.com
FAQ
When will Mesa Labs (MLAB) present at the J.P. Morgan Healthcare Conference?
What time is the Mesa Labs (MLAB) Formal Presentation on January 14, 2026?
Who from Mesa Labs (MLAB) will speak at the January 14, 2026 presentation?
How can investors watch Mesa Labs' (MLAB) J.P. Morgan presentation live?
Will Mesa Labs (MLAB) provide a replay of the J.P. Morgan presentation?
Where is Mesa Labs (MLAB) headquartered and what does it do?
